FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to novel compounds of formula (I), possessing properties, making it possible to inhibit phosphorylation of AKT (proteinkinase B； PKB), to versions of method of their obtaining, as well as to intermediate products for their obtaining. In particular compounds can be applied in treatment of different tumours and/or metastases, as well as in case parasitic diseases such a malaria. In formula (I), R1 stands for -L-phenyl or -L-heteroaryl, with term "heteroaryl" standing for bicyclic radical, containing from 9 to 12 units, L stands for either linear or branched alkyl, containing 1-6 carbon atoms, optionally substituted with hydroxyl, or CO group, or group L'-X, where L' stands for linear or branched alkyl, containing 1-6 carbon atoms, and X stands for oxygen or sulphur atom； with phenyl and heteroaryl being optionally substituted with one or several radicals, similar or different, selected from halogen atoms, -NRxRy, alkoxy and alkyl； with said alkyl being optionally substituted with one or several halogen atoms； R2 stands for hydrogen atom or alkyl； R3 stands for alkyl, optionally substituted with one or several halogen atoms； R4 stands for hydrogen atom or halogen atom； with NRxRy being such that Rx and Ry form together with nitrogen atom, which they are bound to, cyclic radical, including 3-10 units, and optionally oxygen atom； and all alkyl or alkoxy radicals, mentioned above, are linear or branched and contain 1-6 carbon atoms.EFFECT: compounds can be applied as active component for obtaining medications, intended for treatment or prevention of disease, characterised by deregulation of protein- or lipidkinase activity.25 cl, 3 tbl, 43 exИзобретение относится к новым соединениям формулы (I), обладающим свойствами, позволяющими ингибировать фосфорилирование АКТ (протеинкиназы В； РКВ), к вариантам способа их получения, а также к промежуточным продуктам для их получения. Соединения могут найти применение в ка
